Novel Biomarkers for Rejection in Kidney Transplantation: A Comprehensive Review

Area of Science:

• Nephrology
• Transplant Immunology
• Biomarker Discovery

Background:

• Kidney transplantation is the primary treatment for end-stage kidney disease.
• Graft rejection remains a significant challenge despite advances in transplant survival.
• Current monitoring methods (serum creatinine, donor-specific antibodies, proteinuria) and biopsy have limitations in early and accurate rejection detection.

Purpose of the Study:

• To review emerging non-invasive biomarkers for kidney transplant rejection.
• To evaluate the diagnostic and prognostic value of these novel biomarkers.
• To explore their potential in guiding personalized immunosuppression strategies.

Main Methods:

• Literature review of current clinical investigations on novel biomarkers for kidney transplant rejection.
• Analysis of diagnostic performance and prognostic value of candidate biomarkers.
• Focus on biomarkers enabling earlier rejection detection and optimized immunosuppression.

Main Results:

• Non-invasive biomarkers show potential for earlier and more accurate detection of kidney transplant rejection compared to conventional methods.
• These biomarkers may help differentiate rejection from other forms of graft injury.
• Emerging biomarkers could facilitate tailored immunosuppressive regimens.

Conclusions:

• Novel non-invasive biomarkers represent a significant advancement in kidney transplant monitoring.
• They offer a promising alternative to invasive biopsy for timely rejection diagnosis.
• These biomarkers are crucial for optimizing immunosuppression and improving long-term graft survival.